Pulse Biosciences' CellFX Nanosecond Pulsed Field Ablation (nsPFA™) Technology to be Featured in Several Presentations at The Heart Rhythm Society 2024 Annual Meeting | Region
HAYWARD, Calif.--(BUSINESS WIRE)--May 16, 2024--
Stay updated with breaking news from Preclinical Evaluation. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
HAYWARD, Calif.--(BUSINESS WIRE)--May 16, 2024--
Nanoscale tools are revolutionizing tumor physiology research, enhancing our understanding of cancer biology and treatment.
This article describes the features and role of CAR-T therapy in the immunophenotyping and treatmentof solid cancers.
EDEN PRAIRIE, Minn., May 30, 2023 (GLOBE NEWSWIRE) -- Miromatrix Medical Inc. (NASDAQ: MIRO), a life sciences company pioneering a novel technology for...
Pulse Biosciences, Inc. , a company leveraging its novel and proprietary Nanosecond Pulsed Field Ablation technology for the treatment of atrial fibrillation, today announced nsPFA will be featured... | May 18, 2023